Home Sign In About Curriculum Ask the Experts     New!   Additional Information Target Audience Programme Goal Learning Objectives Certificate Requirements Faculty Roster Disclosures Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Novartis Oncology

Created in consultation with
Projects In Knowledge®, developers of certificate programs in medicine.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

Course materials have been developed for use outside of the United States.

grid
banner
View information by clicking on column heads and/or using drop down boxes below.

      Show Coming Soon


CURRENT CURRICULA
  Curriculum 4
  Curriculum 3
  Curriculum 2
  Curriculum 1
 
Curriculum 4 Curriculum 3 Curriculum 2 Curriculum 1
  TITLE FACULTY TOPIC DISEASE STATE
1-IC07.05  Indications for Successful Iron Overload Treatments and Monitoring: Other Anaemias —Webcast (Dec 2008) 1827 Inati
Epidemiology & Pathology
Iron Toxicity and Clinical Sequelae
Diagnosis of Iron Overload
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Iron Deficiency Anaemia/Rare Anaemia

1-IC07.04  Indications for Successful Iron Overload Treatments and Monitoring: Myelodysplastic Syndromes —Webcast (Mar 2008) 1824 Gattermann
Epidemiology & Pathology
Iron Toxicity and Clinical Sequelae
Diagnosis of Iron Overload
Treatment and Monitoring of Iron Overload
Myelodysplastic Syndromes

1-IC04.01  Iron Toxicity and Clinical Sequelae —Webcast (Mar 2008) 1821 Porter
Iron Metabolism/Regulation
Epidemiology & Pathology
Iron Toxicity and Clinical Sequelae
Myelodysplastic Syndromes
Sickle Cell Disease
Hereditary Haemochromatosis
Thalassaemia
Iron Deficiency Anaemia/Rare Anaemia
Iron Metabolism/Regulation

1-IC07.03  Indications for Successful Iron Overload Treatments and Monitoring: Sickle Cell Disease —Webcast (Mar 2008) 1825 de Montalembert
Iron Toxicity and Clinical Sequelae
Sickle Cell Disease

1-IC04.01  Iron Toxicity and Clinical Sequelae —Webcast (Mar 2008) 1821 Porter
Iron Toxicity and Clinical Sequelae
Hereditary Haemochromatosis
Thalassaemia
Iron Deficiency Anaemia/Rare Anaemia
Iron Metabolism/Regulation

1-IC07.03  Indications for Successful Iron Overload Treatments and Monitoring: Sickle Cell Disease —Webcast (Mar 2008) 1825 de Montalembert
Diagnosis of Iron Overload
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Managing Side Effects and Non-Compliance
Sickle Cell Disease

1-IC07.02  Indications for Successful Iron Overload Treatments and Monitoring: Thalassaemia —Webcast (Feb 2008) 1826 Cappellini
Iron Toxicity and Clinical Sequelae
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Thalassaemia

1-IC07.01  Indications for Successful Iron Overload Treatments and Monitoring: Hereditary Haemochromatosis —Webcast (Feb 2008) 1828 Brissot
Iron Metabolism/Regulation
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Hereditary Haemochromatosis
Iron Metabolism/Regulation

1-IC06.01  Iron Chelation Basics —Webcast (Feb 2008) 1823 Porter
Iron Chelation Therapy
Thalassaemia
Iron Deficiency Anaemia/Rare Anaemia

1-IC05.01  Diagnosis of Iron Overload —Webcast (Feb 2008) 1822 Cappellini
Iron Metabolism/Regulation
Epidemiology & Pathology
Iron Toxicity and Clinical Sequelae
Diagnosis of Iron Overload
Myelodysplastic Syndromes
Sickle Cell Disease
Hereditary Haemochromatosis
Thalassaemia
Iron Deficiency Anaemia/Rare Anaemia
Iron Metabolism/Regulation

1-IC03.01  Iron Deficiency: Clinical Sequelae and Diagnosis —Webcast (Feb 2008) 1820 Beris
Epidemiology & Pathology
Iron Deficiency Anaemia/Rare Anaemia
Iron Metabolism/Regulation

1-IC02.05  Epidemiology and Disease Pathophysiology: Myelodysplastic Syndromes —DownloadablePDF (Feb 2008) 1819.04 Other
Epidemiology & Pathology
Myelodysplastic Syndromes

1-IC02.04  Epidemiology and Disease Pathophysiology:
Sickle Cell Disease
—DownloadablePDF (Nov 2007) 1819.03
Beris
Epidemiology & Pathology
Iron Toxicity and Clinical Sequelae
Sickle Cell Disease

1-IC02.03  Epidemiology and Disease Pathophysiology:
Other Anaemias
—Webcast (Nov 2007) 1818
Taher
Epidemiology & Pathology
Iron Chelation Therapy
Myelodysplastic Syndromes
Thalassaemia
Iron Deficiency Anaemia/Rare Anaemia

1-IC02.02  Epidemiology and Disease Pathophysiology:
Hereditary Haemochromatosis
—Webcast (Oct 2007) 1819
Brissot
Iron Metabolism/Regulation
Epidemiology & Pathology
Diagnosis of Iron Overload
Treatment and Monitoring of Iron Overload
Hereditary Haemochromatosis
Iron Metabolism/Regulation

1-IC02.01  Epidemiology and Disease Pathophysiology: Thalassaemia —Webcast (Sep 2007) 1817 Taher
Epidemiology & Pathology
Diagnosis of Iron Overload
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Thalassaemia

1-IC01.01  End-Organ Damage Resulting from Accumulation of Iron in Cells —Webcast (May 2007) 1798.01 Brissot
Iron Metabolism/Regulation
Epidemiology & Pathology
Iron Toxicity and Clinical Sequelae
Myelodysplastic Syndromes
Sickle Cell Disease
Hereditary Haemochromatosis
Thalassaemia
Iron Metabolism/Regulation

ESH-Centre Hayem, Hôspital Saint-Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France - Contacts
All Rights Reserved - Copyright ESH 2010